Arkolith/Insider Trading/EYPT/Form 4

Lurker Nancy

DirectorEyePoint Pharmaceuticals, Inc. (EYPT) · full profile →Form 4 · filed Jul 2, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
10
0 non-derivative · 10 derivative

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 2, 2025Gift(G)55K—$040K
Jul 2, 2025Gift(G)27K—$027K
Jul 2, 2025Gift(G)27K—$050K
Jul 2, 2025Gift(G)15K—$032K
Jul 2, 2025Gift(G)15K—$035K
Jul 2, 2025Gift(G)31K—$00
Jul 2, 2025Gift(G)31K—$0214K
Jul 2, 2025Gift(G)55K—$0200K
Jul 2, 2025Gift(G)103K—$0178K
Jul 2, 2025Gift(G)103K—$0272K

Transaction Codes

G
Gift

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001562180-25-005229) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML